Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TARS1 | P26639 | 2/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.42 |
| ▸ | PI4KA | P42356 | 2/20 | 0.42 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.42 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.42 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.41 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.41 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.41 |
| ▸ | GAPDH | P04406 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | STAT6 | P42226 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30862415 | 1.00 | TARS1 (0.46) | TARS1ADORA2AADORA3PI4KAPI4K2B | |
| SCHEMBL1275036 | 1.00 | TARS1 (0.46) | TARS1ADORA2AADORA3PI4KAPI4K2B | |
| SCHEMBL31675871 | 0.90 | AHCY (0.41) | ADORA2AADORA3ADORA2BADORA1DOT1L | |
| SCHEMBL23066313 | 0.88 | ADORA3 (0.45) | TARS1ADORA2AADORA3PI4KAPI4K2B | |
| SCHEMBL18011012 | 0.88 | SETD2 (0.44) | ADORA2AADORA3PI4KAPI4K2BPI4K2A | |
| SCHEMBL18011010 | 0.88 | SETD2 (0.44) | ADORA2AADORA3PI4KAPI4K2BPI4K2A | |
| SCHEMBL157247 | 0.85 | ADORA2A (0.41) | ADORA2AADORA3PI4KAPI4K2BPI4K2A | |
| SCHEMBL1300400 | 0.85 | ADORA2A (0.41) | ADORA2AADORA3PI4KAPI4K2BPI4K2A | |
| SCHEMBL15798672 | 0.84 | ADORA3 (0.45) | ADORA2AADORA3PI4KAPI4K2BPI4K2A | |
| SCHEMBL2480939 | 0.84 | PI4KA (0.46) | ADORA2AADORA3PI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022191244-A1 | METHOD FOR DETECTING CORONAVIRUS INFECTION | 国立大学法人熊本大学 | 2022-09-15 | — | — | WO | claimed |
| EP-3387150-A1 | LABEL-FREE ANALYSIS OF RNA CAPPING EFFICIENCY USING RNASE H, PROBES AND LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY | Novartis AG (CH) | 2018-10-17 | — | — | EP | claimed |
| WO-2017098468-A1 | LABEL-FREE ANALYSIS OF RNA CAPPING EFFICIENCY USING RNASE H, PROBES AND LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY | NOVARTIS AG (CH) | 2017-06-15 | — | — | WO | claimed |
| WO-2017011773-A2 | CODON-OPTIMIZED NUCLEIC ACIDS ENCODING ANTIBODIES | MODERNATX, INC. (US) | 2017-01-19 | — | — | WO | claimed |
| WO-2026103936-A1 | CHEMICALLY MODIFIED CIRCULAR RNA MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海元码智药生物技术有限公司 | 2026-05-21 | — | — | WO | disclosed |
| US-20260138117-A1 | ADSORPTION TECHNOLOGY | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2026-05-21 | — | — | US | disclosed |
| WO-2026107144-A1 | RNA SEQUENCE FOR EXPRESSING PROTEIN IN CARDIOMYOCYTES | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2026-05-21 | — | — | WO | disclosed |
| CN-122060818-A | Chemically modified circular RNA molecules, methods of making and uses thereof | 上海元码智药生物技术有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260115324-A1 | Chimeric Antigen Receptors Targeting CD19 | ORNA THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4731233-A1 | EXTRACELLULAR VESICLES FROM REGULATORY B CELLS | Institut National de la Santé et de la Recherche Médicale (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-12612658-B2 | RNA replication using transcription polymerases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-04-28 | — | — | US | disclosed |
| US-12612624-B2 | Light-inducible CRISPR/Cas9 system for genome editing | THE JOHNS HOPKINS UNIVERSITY (US) | 2026-04-28 | — | — | US | disclosed |
| WO-2010036795-A2 | SCREENING METHODS FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS | TRANA DISCOVERY, INC. (US) | 2010-04-01 | — | — | WO | disclosed |
| WO-2008064304-A9 | COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF PROTEIN SYNTHESIS | TRANA DISCOVERY INC (US) | 2008-07-10 | — | — | WO | disclosed |
| WO-2008064304-A2 | COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF INHIBITORS OF PROTEIN SYNTHESIS | TRANA DISCOVERY, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
| EP-1263986-A4 | PLATFORM FOR THE DISCOVERY OF THE BACTERIAL GENES INVOLVED IN RNA MODIFICATION | TAO BIOSCIENCES LLC (US) | 2005-02-23 | — | — | EP | disclosed |
| EP-1263986-A1 | PLATFORM FOR THE DISCOVERY OF THE BACTERIAL GENES INVOLVED IN RNA MODIFICATION | Montclair Group (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-1261734-A1 | GENOMIC ANALYSIS OF tRNA GENE SETS | Montclair Group (US) | 2002-12-04 | — | — | EP | disclosed |
| WO-2001062981-A1 | PLATFORM FOR THE DISCOVERY OF THE BACTERIAL GENES INVOLVED IN RNA MODIFICATION | MONTCLAIR GROUP (US) | 2001-08-30 | — | — | WO | disclosed |
| WO-2001062955-A1 | GENOMIC ANALYSIS OF tRNA GENE SETS | MONTCLAIR GROUP (US) | 2001-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612624-B2 | Light-inducible CRISPR/Cas9 system for genome editing | RNMT, AMPD2, NT5C2 | TARS1 3010/4885ADORA2A 196/4885ADORA3 846/4885 |
| US-20260138117-A1 | ADSORPTION TECHNOLOGY | SLC6A2, PSPH, SLC10A6 | TARS1 4484/4885ADORA2A 147/4885ADORA3 67/4885 |
| US-20260115324-A1 | Chimeric Antigen Receptors Targeting CD19 | BCR, IGLV6-57, BCL6 | TARS1 1301/4885ADORA2A 3674/4885ADORA3 4101/4885 |
| US-12612658-B2 | RNA replication using transcription polymerases | RNGTT, POLRMT, POLM | TARS1 755/4885ADORA2A 712/4885ADORA3 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.